These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
111 related articles for article (PubMed ID: 8581415)
1. Tissue-specific effects of anti-CD4 therapy in induction of allograft unresponsiveness in high and low responder rats. Yin D; Fathman CG Transpl Immunol; 1995 Sep; 3(3):258-64. PubMed ID: 8581415 [TBL] [Abstract][Full Text] [Related]
2. Anti-CD4 therapy in combined heart-kidney, heart-liver, and heart-small bowel allotransplants in high-responder rats. Yin DP; Sankary HN; Talor-Edwards C; Chong AS; Foster P; Shen J; Ma LL; Williams JW; Fathman CG Transplantation; 1998 Jul; 66(1):1-5. PubMed ID: 9679814 [TBL] [Abstract][Full Text] [Related]
3. Induction of tolerance to heart allografts in high responder rats by combining anti-CD4 with CTLA4Ig. Yin D; Fathman CG J Immunol; 1995 Aug; 155(4):1655-9. PubMed ID: 7636225 [TBL] [Abstract][Full Text] [Related]
4. Induction of donor specific transplantation tolerance to cardiac allografts following treatment with nondepleting (RIB 5/2) or depleting (OX-38) anti-CD4 mAb plus intrathymic or intravenous donor alloantigen. Arima T; Lehmann M; Flye MW Transplantation; 1997 Jan; 63(2):284-92. PubMed ID: 9020332 [TBL] [Abstract][Full Text] [Related]
5. Induction of donor-specific unresponsiveness to cardiac allografts in rats by pretransplant anti-CD4 monoclonal antibody therapy. Shizuru JA; Seydel KB; Flavin TF; Wu AP; Kong CC; Hoyt EG; Fujimoto N; Billingham ME; Starnes VA; Fathman CG Transplantation; 1990 Sep; 50(3):366-73. PubMed ID: 1976282 [TBL] [Abstract][Full Text] [Related]
6. The kinetics of tolerance induction by nondepleting anti-CD4 monoclonal antibody (RIB 5/2) plus intravenous donor alloantigen administration. Motoyama K; Arima T; Yu S; Lehmann M; Flye MW Transplantation; 2000 Jan; 69(2):285-93. PubMed ID: 10670640 [TBL] [Abstract][Full Text] [Related]
14. Induction of tolerance to small bowel allografts in high-responder rats by combining anti-CD4 with CTLA4Ig. Yin DP; Sankary HN; Williams J; Krieger N; Fathman CG Transplantation; 1996 Dec; 62(11):1537-9. PubMed ID: 8970603 [TBL] [Abstract][Full Text] [Related]
15. Analysis of donor-specific unresponsiveness to rat allografts by nondepleting anti-CD4 monoclonal antibody (RIB 5/2) plus donor antigen. Motoyama K; Lehmann M; Flye MW Transplant Proc; 1999; 31(1-2):1237-8. PubMed ID: 10083552 [No Abstract] [Full Text] [Related]
16. CTLA4-Ig abrogates the anti-globulin response and prolongs cardiac allograft survival after anti-CD2 treatment. Stell D; Marshall H; Bradley JA; Bolton EM Transpl Immunol; 2003; 12(1):1-7. PubMed ID: 14551027 [TBL] [Abstract][Full Text] [Related]
17. The relative contribution of intrathymic inoculation of donor leukocyte subpopulations in the induction of specific tolerance. Oluwole SF; Chowdhury NC; Jin MX Cell Immunol; 1994 Jan; 153(1):163-70. PubMed ID: 8287488 [TBL] [Abstract][Full Text] [Related]
18. Distinct tolerance pathways in sensitized allograft recipients after selective blockade of activation signal 1 or signal 2. Onodera K; Chandraker A; Volk HD; Ritter T; Lehmann M; Kato H; Sayegh MH; Kupiec-Weglinski JW Transplantation; 1999 Jul; 68(2):288-93. PubMed ID: 10440403 [TBL] [Abstract][Full Text] [Related]
19. The use of granzyme A as a marker of heart transplant rejection in cyclosporine or anti-CD4 monoclonal antibody-treated rats. Chen RH; Ivens KW; Alpert S; Billingham ME; Fathman CG; Flavin TF; Shizuru JA; Starnes VA; Weissman IL; Griffiths GM Transplantation; 1993 Jan; 55(1):146-53. PubMed ID: 8420039 [TBL] [Abstract][Full Text] [Related]